Molecule of the year
At their core, biochemistry and molecular biology are all about how molecules interact.
Molecules catalyze reactions, form structural components and help carry important signals from one end of a system to the other. Proteins, nucleic acids, lipids, carbohydrates, metabolites and small molecules all play important roles in the vast network of life’s processes.
We invite you to nominate what you consider to be the most influential molecular discoveries and innovations for our inaugural "Molecule of the Year" contest.
Here’s how it works:
- From now until May 17, you can submit your nomination for the molecule of the year.
- From May 27 until June 14, all ASBMB members will have the chance to vote for the molecule they think is deserving of the title “Molecule of the Year.”
This is your chance to recognize the discoveries at the heart of groundbreaking advancements, whether it's a revolutionary drug, an important metabolite or an incredible enzyme. Nominate your choice for the Molecule of the Year and let's shine a spotlight on the molecules that make the world go round.
Questions? Contact Joanna Kotloski, membership director.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.